Research

ISCI Research

Basic Cell Biology, Blood, Bone & Skin, Cancer, Cardiovascular, Diabetes and Nervous System.

Clinical Trials

Clinical Trials

Phase I/II clinical trials testing mesenchymal stem cells (MSC) in cardiology and wound care.

Leadership

ISCI Leadership

Renowned physician-scientists set a vision for the future of regenerative medicine.

Latest News

Mesenchymal Stromal Cells Shown to Prevent Lung and Skin Fibrosis, Restore Wound Healing

A cross-disciplinary group of researchers at the University of Miami Miller School of Medicine has found that allogeneic adipose-derived mesenchymal stromal cells (ASCs) will prevent lung and skin fibrosis, and restore wound healing.

Read more on the Miller School Web site »

51st Miami Winter Symposium Opens January 28

Stem Cells: Today’s Research Tomorrow’s Therapies will be the focus of the 51st Miami Winter Symposium, which will take place January 28-31 at the downtown Hyatt Regency Hotel January 28-31.

Read more on the Miller School Web site »

Stem Cell Studies Build Momentum toward Therapy for Age-Associated Frailty

Buoyed by promising results of a Phase I study demonstrating the safety of mesenchymal stem cell therapy to treat frailty in older adults, researchers at the Interdisciplinary Stem Cell Institute (ISCI) at the University of Miami Miller School of Medicine have taken it a step further. Now Phase II randomized, placebo-controlled trial findings have verified their initial study.

Read more on the Miller School Web site »